Hims & Hers Health, Inc.

HIMS stock score: 51/100

$29.13 · -0.27% · Scored Oct 22, 2026

Technical
47
Fundamental
55
News
55

The reading

Hims & Hers Health (HIMS) scores 51 out of 100, which reads neutral, higher than 66% of Healthcare stocks and 46% of the 4,161 US stocks we score.

The composite is technicals and fundamentals weighted equally: technicals read 47, fundamentals 55.

Among the fundamentals, Fair Value at 100 and Revenue Growth (5-Year) at 100 score highest, while Earnings Growth (Quarterly) at 0 weighs the most against it.

On the daily chart, trend-following indicators average 38 and contrarian oscillators 48.

News sentiment is neutral at 55; it is shown, not counted in the composite.

Since Jul 25, 2026 the composite has ranged from 36 to 61, and it is down 10 points over the period.

What’s driving the score

The strongest and weakest of the scorers that count toward HIMS’s composite. Each returns 0–100, higher is more bullish — including metrics where low is good, like P/E.

Fundamental

55

Pulling it up

  • Fair Value100

    Fair value score synthesizes multiple valuation methods (DCF, P/E, P/B, P/S) to estimate intrinsic worth.

  • Revenue Growth (5-Year)100

    5-year revenue growth analyzes long-term sales trajectory and consistency.

  • Revenue Quality (Quarterly)100

    Revenue Quality (Quarterly) evaluates recent revenue performance using trailing 12-month data from quarterly reports.

Holding it back

  • Earnings Growth (Quarterly)0

    Quarterly earnings growth measures profit increase versus the prior-year quarter.

  • Price to Book Ratio1

    Price-to-Book ratio compares market value to book value.

  • Operating Margins2

    Operating margins measure profitability after operating expenses.

40 weighted scorers; 1 had no data today and are left out rather than counted as zero.

Technical · daily

39

Pulling it up

  • Candlestick Patterns100

    Candlestick patterns recognize specific price formations that historically suggest continuation or reversal.

  • Know Sure Thing (KST)82

    Know Sure Thing (KST) combines multiple rate-of-change calculations to identify long-term trend reversals.

  • SMA 200 Cross Up73

    SMA 200 Cross Up tracks when faster moving averages cross above the 200-period SMA.

Holding it back

  • S&P 500 52W Comparison0

    S&P 500 52-week comparison evaluates the stock's annual performance relative to the broader market.

  • Parabolic SAR (PSAR)0

    Parabolic SAR (Stop and Reverse) provides trailing stop levels that follow price trends.

  • 52-Week Change10

    The price change over the last 52 weeks.

62 weighted scorers; 3 had no data today and are left out rather than counted as zero.

News · shown, not counted

Global News
55

Technical score by timeframe

ChartScoreWeight
Hourly461
Daily393
Weekly462
Monthly492
Quarterly602

Composite score, last 90 days

05010051Jul 25, 2026Oct 22, 2026Jul 25, 2026: 61Jul 26, 2026: 61Jul 27, 2026: 61Jul 28, 2026: 60Jul 29, 2026: 59Jul 30, 2026: 60Jul 31, 2026: 39Aug 2, 2026: 36Aug 3, 2026: 38Aug 4, 2026: 40Aug 5, 2026: 39Aug 6, 2026: 37Aug 7, 2026: 54Aug 8, 2026: 54Aug 9, 2026: 54Aug 10, 2026: 53Aug 11, 2026: 52Aug 12, 2026: 51Aug 13, 2026: 49Aug 14, 2026: 49Aug 15, 2026: 50Aug 16, 2026: 50Aug 17, 2026: 50Aug 18, 2026: 49Aug 19, 2026: 53Aug 20, 2026: 56Aug 22, 2026: 58Aug 23, 2026: 58Aug 24, 2026: 55Aug 25, 2026: 56Aug 26, 2026: 53Aug 27, 2026: 55Aug 28, 2026: 51Aug 29, 2026: 51Aug 30, 2026: 52Aug 31, 2026: 51Sep 1, 2026: 50Sep 2, 2026: 49Sep 3, 2026: 48Sep 4, 2026: 48Sep 5, 2026: 48Sep 6, 2026: 48Sep 7, 2026: 49Sep 8, 2026: 50Sep 9, 2026: 48Sep 10, 2026: 48Sep 11, 2026: 48Sep 12, 2026: 48Sep 13, 2026: 48Sep 14, 2026: 51Sep 15, 2026: 50Sep 16, 2026: 49Sep 17, 2026: 49Sep 18, 2026: 50Sep 19, 2026: 50Sep 20, 2026: 50Sep 21, 2026: 52Sep 22, 2026: 56Sep 23, 2026: 52Sep 24, 2026: 51Sep 25, 2026: 53Sep 26, 2026: 52Sep 27, 2026: 52Sep 28, 2026: 51Sep 29, 2026: 51Sep 30, 2026: 55Oct 1, 2026: 52Oct 2, 2026: 53Oct 3, 2026: 53Oct 4, 2026: 53Oct 5, 2026: 54Oct 6, 2026: 54Oct 7, 2026: 53Oct 8, 2026: 49Oct 9, 2026: 55Oct 10, 2026: 55Oct 11, 2026: 55Oct 12, 2026: 56Oct 13, 2026: 53Oct 14, 2026: 49Oct 15, 2026: 50Oct 16, 2026: 50Oct 17, 2026: 51Oct 18, 2026: 51Oct 19, 2026: 50Oct 20, 2026: 53Oct 21, 2026: 54Oct 22, 2026: 51
Show the daily numbers
DateComposite
Oct 22, 202651
Oct 21, 202654
Oct 20, 202653
Oct 19, 202650
Oct 18, 202651
Oct 17, 202651
Oct 16, 202650
Oct 15, 202650
Oct 14, 202649
Oct 13, 202653
Oct 12, 202656
Oct 11, 202655
Oct 10, 202655
Oct 9, 202655
Oct 8, 202649
Oct 7, 202653
Oct 6, 202654
Oct 5, 202654
Oct 4, 202653
Oct 3, 202653
Oct 2, 202653
Oct 1, 202652
Sep 30, 202655
Sep 29, 202651
Sep 28, 202651
Sep 27, 202652
Sep 26, 202652
Sep 25, 202653
Sep 24, 202651
Sep 23, 202652
Sep 22, 202656
Sep 21, 202652
Sep 20, 202650
Sep 19, 202650
Sep 18, 202650
Sep 17, 202649
Sep 16, 202649
Sep 15, 202650
Sep 14, 202651
Sep 13, 202648
Sep 12, 202648
Sep 11, 202648
Sep 10, 202648
Sep 9, 202648
Sep 8, 202650
Sep 7, 202649
Sep 6, 202648
Sep 5, 202648
Sep 4, 202648
Sep 3, 202648
Sep 2, 202649
Sep 1, 202650
Aug 31, 202651
Aug 30, 202652
Aug 29, 202651
Aug 28, 202651
Aug 27, 202655
Aug 26, 202653
Aug 25, 202656
Aug 24, 202655
Aug 23, 202658
Aug 22, 202658
Aug 20, 202656
Aug 19, 202653
Aug 18, 202649
Aug 17, 202650
Aug 16, 202650
Aug 15, 202650
Aug 14, 202649
Aug 13, 202649
Aug 12, 202651
Aug 11, 202652
Aug 10, 202653
Aug 9, 202654
Aug 8, 202654
Aug 7, 202654
Aug 6, 202637
Aug 5, 202639
Aug 4, 202640
Aug 3, 202638
Aug 2, 202636
Jul 31, 202639
Jul 30, 202660
Jul 29, 202659
Jul 28, 202660
Jul 27, 202661
Jul 26, 202661
Jul 25, 202661

Key facts

Market cap
$6.8B
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Beta
2.43
Risk grade (1–10)
9
Next earnings
Nov 9, 2026

Drug Manufacturers - Specialty & Generic peers

CompanyMarket capScore
RDY Dr. Reddy's Laboratories$11.0B54
ALKS Alkermes$7.4B58
AMRX Amneal Pharmaceuticals$7.1B65
LNTH Lantheus$6.5B65
KNSA Kiniksa Pharmaceuticals International$6.3B65
RGC Regencell Bioscience Holdings$4.9B36

Questions

What is HIMS's stock score today?

HIMS scores 51/100 (Neutral) as of Oct 22, 2026: technical 47, fundamental 55, and news sentiment 55, which is shown but not counted. Scores are recomputed every night.

Is HIMS a buy?

The score is not a buy or sell recommendation. A 51 says the technical and fundamental signals we measure lean neutral today, relative to every other stock scored the same way. Use the breakdown above to see why, and treat it as a starting point for your own research.

How is the HIMS score calculated?

102 weighted scorers feed it today: 40 fundamental, scored against Healthcare ranges, and 62 technical on the daily chart, with 5 timeframes blended into the technical total. Every scorer returns 0–100; missing data is left out, never counted as zero.

Scores are information, not investment advice. Computed from Yahoo Finance, Finnhub and Alpha Vantage data; technical indicators via TA-Lib. Past scores do not predict future returns.